Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 11 min ago
Peer-reviewedCC BY 4.0Journal of Clinical Medicine

Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment

  • Hirsh D. Trivedi1
  1. 1Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, TX 78712, USA
Open at sourceDOICite

Abstract

Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease in the world [...]

Related

  1. Metabolic dysfunction-associated steatotic liver disease: Pathogenesis, complications and pharmacological treatment
    Kyung-Soo Kim, Soo Lim, Cheol-Young Park
    EXCLI JournalPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  2. Efficacy and safety of GLP-1 receptor agonists in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) : A systematic review and meta-analysis
    Mohammed Alfawaz, Dareen Bajamaan, Lama Alghamdi +7
    MedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Efficacy of plant extracts for metabolic dysfunction-associated steatotic liver disease: a network meta-analysis
    Zhenghong Xie, Tianxing Chen
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Tirzepatide use in adolescents with metabolic dysfunction‐associated steatotic liver disease (MASLD): A case series
    Brandon J. Perumpail, Andrea Tou, Jennifer Panganiban
    JPGN reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Functional and Metabolic Correlates of Age- and Sex-Normalized Handgrip Strength in Children with Metabolic Dysfunction-Associated Steatotic Liver Disease
    Mohit Kehar, Carolina Jimenez-Rivera, Leah Feret +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC

Cite

BibTeXRIS
BibTeX
@article{trivedi2026clinical,
  title = {{Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment}},
  author = {Hirsh D. Trivedi},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  month = nov,
  doi = {10.3390/jcm15218634},
  url = {https://www.mdpi.com/2077-0383/15/21/8634},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Clinical Advances in Metabolic Dysfunction-Associated Steatotic Liver Disease: Context, Measurement, and Treatment
AU  - Hirsh D. Trivedi
PY  - 2026
DA  - 2026/11/05
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm15218634
UR  - https://www.mdpi.com/2077-0383/15/21/8634
AB  - Metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease in the world [...]
SN  - 2077-0383
ER  -